All eyes on sales momentum for Eli Lilly's obesity drug Zepbound
Pharmaceutical giant Eli Lilly (LLY:NYSE) is due to report first-quarter earnings before the market opens on 30 April. Wall Street is expecting EPS (earnings per share) of $2.54 which represents a 57% increase compared with the...
25 April 2024